Skip to content
Certified ManufacturersFor manufacturers

Tishcon Corp.

Westbury, NY, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

Tishcon Corp. is a dietary supplement manufacturer in Westbury, NY, United States, certified to NSF/ANSI 455-2 GMP, with 7 manufacturing facilities on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, powders, softgels and tablets.

Facilities listed
10
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

  • 818 Brown Street, Salisbury, MD 21804, United States

    Manufacturing
    • Coating
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing
  • 41 New York Avenue, Westbury, NY 11590, United States

    Manufacturing
    • Quality Unit Operations
  • 36 New York Avenue, Westbury, NY 11590, United States

    Manufacturing
    • Encapsulation
    • Liquid Formulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Quality Unit Operations
  • 30 New York Avenue, Westbury, NY 11590, United States

    Manufacturing
    • Encapsulation
    • Liquid Formulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Quality Unit Operations
  • 2410 N. Zion Road, Salisbury, MD 21801, United States

    Manufacturing
    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing
  • 28 New York Avenue, Westbury, NY 11590, United States

    Manufacturing
    • Warehousing
Show all 10 facilities, grouped by type

Manufacturing (7)

  • 818 Brown Street, Salisbury, MD 21804, United States

    • Coating
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing
  • 41 New York Avenue, Westbury, NY 11590, United States

    • Quality Unit Operations
  • 36 New York Avenue, Westbury, NY 11590, United States

    • Encapsulation
    • Liquid Formulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Quality Unit Operations
  • 30 New York Avenue, Westbury, NY 11590, United States

    • Encapsulation
    • Liquid Formulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Quality Unit Operations
  • 2410 N. Zion Road, Salisbury, MD 21801, United States

    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing
  • 28 New York Avenue, Westbury, NY 11590, United States

    • Warehousing
  • 17 Brooklyn Avenue, Westbury, NY 11590, United States

    • Warehousing

Distribution (3)

  • 28 New York Avenue, Westbury, NY 11590, United States

    • Warehousing
  • 608 Main Street, Westbury, NY 11590, United States

    • Warehousing
  • 17 Brooklyn Avenue, Westbury, NY 11590, United States

    • Warehousing

How Tishcon Corp. compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

No food or dietary supplement recall found under the name Tishcon Corp. in FDA’s enforcement reports, as of .

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 12 food or dietary supplement inspections at facilities matching Tishcon Corp., from 2009 to 2025, as of . 5 found no objectionable conditions and 7 found conditions the firm was left to correct.

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Salisbury, Maryland

    7 citations posted:

    • Physical plant - clean and sanitary (21 CFR 111.15(b))
    • Equipment - design - appropriate and suitable (21 CFR 111.27(a))
    • Specifications - components (21 CFR 111.70(b))
    • Specifications - finished dietary supplement (21 CFR 111.70(e))
    See all 7 citations
    • Physical plant - clean and sanitary (21 CFR 111.15(b))

      You did not maintain your physical plant in a clean and sanitary condition.

    • Equipment - design - appropriate and suitable (21 CFR 111.27(a))

      You did not use equipment or utensils suitable for its intended use.

    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for identity, purity and strength.

    • Batch record - required information (21 CFR 111.260)

      Your batch production record did not include all required information.

    • Conditions, controls -protect; microorganisms, contamination (21 CFR 111.365(a))

      You did not perform manufacturing operations under conditions and controls that protect against the potential for contamination.

    • Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))

      You held dietary supplements under conditions that lead to mix-up, contamination, or deterioration.

    FEI 1122227

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Westbury, New York

    5 citations posted:

    • Specifications - components (21 CFR 111.70(b))
    • Specifications - finished dietary supplement (21 CFR 111.70(e))
    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
    • Hold - temperature, humidity, light (21 CFR 111.455(a))
    See all 5 citations
    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for identity, purity, strength and composition.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Hold - temperature, humidity, light (21 CFR 111.455(a))

      You did not hold dietary supplements under appropriate conditions of temperature, humidity, or light so that their identity, purity, strength, and composition are not affected.

    • Product complaint - review, investigation (21 CFR 111.560(c))

      Your review and investigation of a product complaint did not extend to all relevant batches and records.

    FEI 2431390

  • No action indicated · No objectionable conditions found

    Inspected

    Salisbury, Maryland

    FEI 1122227

  • No action indicated · No objectionable conditions found

    Inspected

    Westbury, New York

    FEI 2431390

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Salisbury, Maryland

    3 citations posted:

    • Quality control - processes, specifications, written procedures (21 CFR 111.105(a))
    • Components - contamination, deterioration, mix-ups (21 CFR 111.155(e))
    • Batch record - specifications (21 CFR 111.260(i))
    Full citation text
    • Quality control - processes, specifications, written procedures (21 CFR 111.105(a))

      Your quality control personnel did not approve or reject deviations or modifications that may affect the identity, purity, strength, or composition of a dietary supplement.

    • Components - contamination, deterioration, mix-ups (21 CFR 111.155(e))

      You did not hold components under conditions that will protect against contamination.

    • Batch record - specifications (21 CFR 111.260(i))

      Your batch production records did not include documentation that the finished dietary supplement meets established specifications.

    FEI 1122227

Show all 12 inspections
  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Salisbury, Maryland

    7 citations posted:

    • Physical plant - clean and sanitary (21 CFR 111.15(b))
    • Equipment - design - appropriate and suitable (21 CFR 111.27(a))
    • Specifications - components (21 CFR 111.70(b))
    • Specifications - finished dietary supplement (21 CFR 111.70(e))
    See all 7 citations
    • Physical plant - clean and sanitary (21 CFR 111.15(b))

      You did not maintain your physical plant in a clean and sanitary condition.

    • Equipment - design - appropriate and suitable (21 CFR 111.27(a))

      You did not use equipment or utensils suitable for its intended use.

    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for identity, purity and strength.

    • Batch record - required information (21 CFR 111.260)

      Your batch production record did not include all required information.

    • Conditions, controls -protect; microorganisms, contamination (21 CFR 111.365(a))

      You did not perform manufacturing operations under conditions and controls that protect against the potential for contamination.

    • Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))

      You held dietary supplements under conditions that lead to mix-up, contamination, or deterioration.

    FEI 1122227

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Westbury, New York

    5 citations posted:

    • Specifications - components (21 CFR 111.70(b))
    • Specifications - finished dietary supplement (21 CFR 111.70(e))
    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
    • Hold - temperature, humidity, light (21 CFR 111.455(a))
    See all 5 citations
    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for identity, purity, strength and composition.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Hold - temperature, humidity, light (21 CFR 111.455(a))

      You did not hold dietary supplements under appropriate conditions of temperature, humidity, or light so that their identity, purity, strength, and composition are not affected.

    • Product complaint - review, investigation (21 CFR 111.560(c))

      Your review and investigation of a product complaint did not extend to all relevant batches and records.

    FEI 2431390

  • No action indicated · No objectionable conditions found

    Inspected

    Salisbury, Maryland

    FEI 1122227

  • No action indicated · No objectionable conditions found

    Inspected

    Westbury, New York

    FEI 2431390

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Salisbury, Maryland

    3 citations posted:

    • Quality control - processes, specifications, written procedures (21 CFR 111.105(a))
    • Components - contamination, deterioration, mix-ups (21 CFR 111.155(e))
    • Batch record - specifications (21 CFR 111.260(i))
    Full citation text
    • Quality control - processes, specifications, written procedures (21 CFR 111.105(a))

      Your quality control personnel did not approve or reject deviations or modifications that may affect the identity, purity, strength, or composition of a dietary supplement.

    • Components - contamination, deterioration, mix-ups (21 CFR 111.155(e))

      You did not hold components under conditions that will protect against contamination.

    • Batch record - specifications (21 CFR 111.260(i))

      Your batch production records did not include documentation that the finished dietary supplement meets established specifications.

    FEI 1122227

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Westbury, New York

    3 citations posted:

    • Specifications identity, purity strength, composition (21 CFR 111.70(c)(2))
    • Specifications met - verify; finished batch (21 CFR 111.75(c))
    • Specifications not met - identity; component, reject (21 CFR 111.77(b))
    Full citation text
    • Specifications identity, purity strength, composition (21 CFR 111.70(c)(2))

      You did not provide adequate documentation of your basis for why meeting the in-process specifications, in combination with meeting component specifications, will help ensure that the specifications are met for the identity, purity, strength and composition.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength and composition.

    • Specifications not met - identity; component, reject (21 CFR 111.77(b))

      Your quality control personnel did not reject a component that did not meet an identity specification.

    FEI 2431390

  • No action indicated · No objectionable conditions found

    Inspected

    Salisbury, Maryland

    FEI 1122227

  • No action indicated · No objectionable conditions found

    Inspected

    Westbury, New York

    FEI 2431390

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Salisbury, Maryland

    4 citations posted:

    • Production, in- process control system - design, quality (21 CFR 111.60(a))
    • Exempted, periodic testing; quality control (21 CFR 111.75(d)(2))
    • Material review, disposition, follow-up; investigation (21 CFR 111.140 (b)(3)(ii))
    • Records - document; results (21 CFR 111.325(b)(2)(ii))
    Full citation text
    • Production, in- process control system - design, quality (21 CFR 111.60(a))

      Your production and in-process control system is not designed to ensure that the dietary supplement is manufactured, packaged, labeled, and held in a manner that will ensure the quality of the dietary supplement.

    • Exempted, periodic testing; quality control (21 CFR 111.75(d)(2))

      Your quality control personnel did not review and approve the documentation of why an exempted product specification is met without verification through periodic testing of the finished batch.

    • Material review, disposition, follow-up; investigation (21 CFR 111.140 (b)(3)(ii))

      Your documentation of your material review and disposition decision and follow-up did not include a description of your investigation into the cause of the deviation from the specification or of the unanticipated occurrence.

    • Records - document; results (21 CFR 111.325(b)(2)(ii))

      The documentation for laboratory tests and examinations did not include the results of the testing and examination.

    FEI 1122227

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Salisbury, Maryland

    FEI 1122227

  • No action indicated · No objectionable conditions found

    Inspected

    Salisbury, Maryland

    1 citation posted:

    • Absence of Written Procedures (21 CFR 211.100(a))
    Full citation text
    • Absence of Written Procedures (21 CFR 211.100(a))

      There are no written procedures for production and process controls designed to assure that the drug products have the identity, strength, quality, and purity they purport or are represented to possess.

    FEI 1122227

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Salisbury, Maryland

    3 citations posted:

    • Changes to Procedures Not Reviewed, Approved (21 CFR 211.100(a))
    • Complete instructions, procedures, specifications et. al. (21 CFR 211.186(b)(9))
    • Written record of investigation incomplete (21 CFR 211.192)
    Full citation text
    • Changes to Procedures Not Reviewed, Approved (21 CFR 211.100(a))

      Changes to written procedures are not drafted, reviewed and approved by the appropriate organizational unit and reviewed and approved by the quality control unit.

    • Complete instructions, procedures, specifications et. al. (21 CFR 211.186(b)(9))

      Master production and control records lack specifications.

    • Written record of investigation incomplete (21 CFR 211.192)

      Written records of investigations into unexplained discrepancies do not include the conclusions and follow-up.

    FEI 1122227

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What Tishcon Corp. says it offers

From Tishcon Corp.’s own website, checked . Not verified by us.

Products

  • Herbal & botanicalShow quote“Tishcon manufactures the highest quality standardized herbal extracts in softgels.”
    “Tishcon manufactures the highest quality standardized herbal extracts in softgels.”

    Source page · seen on

  • Vitamins & mineralsShow quote“Tishcon is a leading manufacturer of chewable supplements with proven expertise in chewable multivitamin formulations.”
    “Tishcon is a leading manufacturer of chewable supplements with proven expertise in chewable multivitamin formulations.”

    Source page · seen on

Services

  • Custom formulationShow quote“From custom formulations to contract manufacturing, Tishcon helps clients put their product vision into the hands of consumers.”
    “From custom formulations to contract manufacturing, Tishcon helps clients put their product vision into the hands of consumers.”

    Source page · seen on

  • Contract manufacturingShow quote“From custom formulations to contract manufacturing, Tishcon helps clients put their product vision into the hands of consumers.”
    “From custom formulations to contract manufacturing, Tishcon helps clients put their product vision into the hands of consumers.”

    Source page · seen on

  • TurnkeyShow quote“We can provide a turn-key capability to take your product from concept to market.”
    “We can provide a turn-key capability to take your product from concept to market.”

    Source page · seen on

  • Packaging & bottlingShow quote“As a leading contract manufacturer for health and nutrition products, we offer a wide range of packaging options for your products.”
    “As a leading contract manufacturer for health and nutrition products, we offer a wide range of packaging options for your products.”

    Source page · seen on

Product certifications it claims

  • VeganShow quote“All of our vegan formulations are manufactured to strict vegan specifications in our GMP-certified facilities”
    “All of our vegan formulations are manufactured to strict vegan specifications in our GMP-certified facilities”

    Source page · seen on

  • Non-GMOShow quote“we are able to meet the demand for formulations that are 100% non-GMO.”
    “we are able to meet the demand for formulations that are 100% non-GMO.”

    Source page · seen on

  • HalalShow quote“Halal Certified - both plants NY & MD”
    “Halal Certified - both plants NY & MD”

    Source page · seen on

  • Gluten-freeShow quote“Tishcon manufactures gluten-free vitamins and supplements.”
    “Tishcon manufactures gluten-free vitamins and supplements.”

    Source page · seen on

  • Organic productsShow quote“Tishcon manufactures the highest quality organic products.”
    “Tishcon manufactures the highest quality organic products.”

    Source page · seen on

We read the company’s public web pages and keep a claim only when its quote appears on the page. A claim is hidden once we haven’t seen it for 120 days. Spotted something wrong? Tell us · How we collect website claims

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • 10 facility addresses
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.
  • What the company’s own website says it makes and offers, shown above with quotes

Ask about these in your quote request. How we verify

Other capsule manufacturers in the United States

  1. NSF lists 5 capsule facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a capsule facility in Centennial, CO

    Centennial, CO, United States5280smc.com

    • Capsules
    Operations:
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists a capsule facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a capsule facility in Ada, MI

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists 2 capsule facilities, including one in Chandler, AZ

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a capsule facility in Congers, NY

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026